NASDAQ: HSIC
Healthcare · Medical - Distribution
After hours: $86.51(0%) · as of 4:20 PM ET
Market Cap
$9.85B
52w High
$89.34
52w Low
$61.95
P/E
25.42
Volume
1.88M
Outstanding Shares
113.92M
Price vs Fundamentals
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
The stock rose 23.55% over the last year. Revenue grew 5.64% over the trailing twelve months. Operating margin moved from 6.1% to 5.6%. Free cash flow declined 16.8% over the trailing twelve months.
The stock is rising despite deteriorating fundamentals and now sits at the 93rd percentile of its historical P/FCF range. This is a momentum-driven move — the market may be front-running a recovery that has not yet appeared in reported numbers.
Operating margin (currently 5.6%) would need to stabilize or improve to justify the move. This read is wrong if the next period shows operating metrics turning the corner. At that point the price would be anticipating real improvement rather than running ahead of it.
Company profile
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services.
Valuation
Stock splits
Every 40 shares became 51
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
15
Buy
15
Hold
3
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2026
Q3 FY26 · EPS est $1.24 · Revenue est $3.37B
View